Female sex was associated with a higher total plaque burden of 24% compared to 23% in male counterparts, indicating significant sex differences in plaque phenotype among non-obstructive CAD patients.
Cross-Sectional (n=1,189)
Yes
Does sex and age impact coronary artery plaque phenotype and total plaque burden in patients with non-obstructive coronary artery disease?
Effect estimate: β=1.0 (95% CI 0.5 to 1.5)
Absolute Event Rate: 24% vs 23%
p-value: p=<0.001
Background Coronary artery disease (CAD) progression and risk of cardiac events differ between women and men during the lifespan. Accordingly, we aimed to explore the impact of sex and age on plaque phenotype in non-obstructive CAD. Method We included 1189 patients with non-obstructive CAD (48% women) from the Norwegian Registry of Invasive Cardiology and quantitatively assessed each patient’s plaque phenotype by coronary CT angiography. Plaque subtypes included calcified (>350 Hounsfield units HU), fibrous (131 to 350 HU), fibrofatty (76 to 130 HU) and necrotic core plaques (−30 to 75 HU). The impact of sex on plaque phenotype was assessed after age stratification (≤50, 51–64 and ≥65 years). Results Total plaque burden adjusted for vessel volume was higher in middle-aged and older women compared with men (all p<0.05). Women had lower proportions of fibrofatty plaques compared with men across all age groups, while middle-aged and older women had higher proportions of calcified and fibrous plaques compared with men. Middle-aged and older men had higher proportions of necrotic core plaques compared with women (all p<0.05). After adjusting for cardiovascular risk factors, female sex remained independently associated with total plaque burden (β=1.0 0.5 to 1.5, p<0.001), and younger age and male sex with fibrofatty plaque burden (β=−2.8 −4.4 to −1.2, p<0.001, and β=−3.8 −4.9 to −2.8, p<0.001, respectively). Conclusion In non-obstructive CAD, female sex was associated with a higher total plaque burden, whereas male sex and younger age were associated with a higher proportion of vulnerable fibrofatty plaques. Our results highlight important sex differences in plaque phenotypes among patients with non-obstructive CAD during the lifespan, which may impact risk-stratification. Trial registration number NCT04009421 .
Hondros et al. (Tue,) conducted a cross-sectional in non-obstructive coronary artery disease (n=1,189). Coronary CT angiography vs. Control group (male patients) was evaluated on Total plaque burden (β=1.0, 95% CI 0.5 to 1.5, p=<0.001). Female sex was associated with a higher total plaque burden of 24% compared to 23% in male counterparts, indicating significant sex differences in plaque phenotype among non-obstructive CAD patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: